Business Type:
Manufacturer/Factory,Trading Company
Business Range:
Anti-Tumor Drug (Recombinant Human Endostatin Injection, Pemetrexed disodium for Injection, Palonosetron Hydrochloride for Injection, Nedaplatin for Injection), Central Nervous Drug (Edaravone injection), Anti-Infection Drug (Biapenem for Injection), Card
Establishment:
1995
R&D Capacity:
OEM, ODM, Others
Terms of Payment:
LC, T/T, D/P, Paypal, Western Union
Main Markets:
Domestic Market, Southeast Asia, Western Europe
Simcere was founded on March 28, 1995 with an enterprise mission to "discover and develop high-quality medicines for patients." Since its inception, we have grown from a registered capital of 2.78 mil...
1
- YRS
